BLSH enters its August 13 earnings print with the borrow market under sustained strain — a story that has run for weeks and shows no sign of easing. Availability has been below 15% on most trading days since early July, and touched near-zero on multiple occasions. The current reading of 6.4% means roughly one share remains available for every fifteen already borrowed — a persistently tight lending pool that keeps short sellers under pressure. Short interest itself has pulled back meaningfully, down 8% on the week and 31% over the past month to 5.6% of the free float, suggesting some bears have been covering rather than pressing. Cost to borrow has also fallen sharply — from above 8% in early July to around 1.2% now — consistent with a market where short positioning is declining rather than building. The ORTEX short score remains elevated at 74.2, ranking BLSH in the 3rd percentile of short interest rank and 2nd percentile on availability rank. Options, by contrast, offer little drama: the put/call ratio runs at 0.57, slightly below its 20-day average of 0.60, with a z-score of -0.72 — call-skewed rather than defensively positioned. The stock has added 3.3% on the week and 1.7% on the month, closing at $24.63.
The analyst debate on BLSH is genuinely split. JP Morgan's Kenneth Worthington slashed his target from $43 to $26 in mid-June — a cut of nearly 40% while keeping a Neutral rating — the starkest downgrade signal in the recent record and a significant step below the current stock price. The mean analyst target sits around $40, implying roughly 65% upside from current levels, though that average is dragged up by Citi's $65 target, which dates from March 2026 and may not reflect more recent developments. Bulls point to the Equiniti acquisition as a structural catalyst, arguing that Bullish is building an institutional-grade digital asset and custody platform positioned for the tokenization of securities. Bears focus on flat revenue growth, a miss in adjusted EBITDA driven by seasonal Events weakness, and ongoing exposure to cryptocurrency volume volatility. Forward EPS growth expectations are extraordinary on paper — BLSH ranks in the 96th percentile on 12-month forward EPS growth — but momentum scores over 30 and 90 days have deteriorated sharply, and the stock remains deeply below where it traded earlier in 2026.
Institutional ownership adds a layer of interest. FMR (Fidelity) added 3.7 million shares through June 30, lifting its stake to 6.9% of shares outstanding, while ARK Investment Management added 1.7 million shares through July 31, bringing its position to 4.3%. Both are active additions into a stock that has fallen sharply year-to-date, signaling conviction from two well-followed managers on opposite sides of the risk spectrum. Founder Brendan Blumer controls 25.8% of shares, a concentration that limits the effective float and likely contributes to the persistent tightness in the borrow market. On the insider side, CEO Thomas Farley sold just over $3.5 million in shares across multiple tranches in May 2026, though that data is now slightly stale and the sales followed an equity award, limiting the bearish read.
The print will test whether Bullish's Equiniti integration is generating measurable revenue contribution and whether the company can sustain EBITDA margins around 38% without the seasonal Events tailwind — the core questions separating the $26 bear case from the $43-plus bull case.
See the live data behind this article on ORTEX.
Open BLSH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
